# The Human Medicines (Amendment etc.) (EU Exit) (No. 2) Regulations 2021, Regulation 19: Amendment of regulation 202A (licensing authority power in relation to medicinal products subject to additional monitoring)


For regulation 202A(1) substitute—
“(1) The licensing authority may establish a list of medicinal products that are subject to additional monitoring and that are authorised under—
(a) a UKMA(GB), and
(b) a UKMA(UK) where the medicinal product is not on the list referred to in Article 23 of Regulation (EC) No 726/2004.”

---
Source: https://www.legislation.gov.uk/ukdsi/2021/9780348228755/regulation/19 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-no-2-regulations-2021/regulation-19
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.